A combo of cryoballoon ablation and novel oral anticoagulants might be a more effective treatment route than standard care for obese AFib patients, who, according to an Oct. 4 study, are less likely to benefit from traditional catheter ablation in the long-term.

Evidence published in BMJ Heart last month supports the idea of an “obesity paradox” in heart failure, further complicating a long-running debate as to whether extra weight can be cardioprotective in patients with established CVD.

Low birth weight is associated with poorer health outcomes—including CVD—later in life, according to a study out of West Virginia University.

The Centers for Disease Control and Prevention doubled down on its warnings about vaping products Oct. 3 after new numbers revealed more than 1,000 reports of vaping-related lung illness and 18 fatalities in recent weeks.

Researchers are calling for better implementation of ICD therapy after an analysis of the Swedish HF Registry found the devices to be beneficial—but underused—among patients with HFrEF.

Transient endothelial dysfunction stemming from mental duress was associated with a 78% increase in the incidence of MACE in a study of patients with stable CAD, providing scientists with a look at just how much psychological stress can influence our risk of CVD.

A poll conducted by researchers at Fairleigh Dickinson University in New Jersey has revealed that a quarter of Americans take daily low-dose aspirin at some point in their lives, but the majority of those people don’t have heart disease or another chronic illness.

Victims of cardiac arrest are more likely to recover with good brain function if they’re subject to “cooling” after resuscitation, UPI.com reported via HealthDay News Oct. 2.